Team science propels research in pancreatic cancer, one of the most dangerous gastrointestinal cancers. Collaboration is key for Yale scientists.
- May 11, 2022
Viruses and Cancer: How a 45-year Legacy of Collaboration Led to Discoveries about Epstein-Barr, SV40
A 45-year grant led to genomic sequencing of the SV40 virus and other key findings about viruses that cause cancer…
- May 10, 2022
Machine learning algorithms accelerate biomedical research in viral infection, cardiovascular disease, breast cancer and more at Yale’s van Dijk Lab.
- May 03, 2022
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 87 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2022 Best Doctors guide.
- April 28, 2022Source: EIN Presswire
The Federation of American Societies for Experimental Biology (FASEB) today announced the recipients of its 2021 Excellence in Science Awards.
- April 18, 2022
Greco hopes to advance the transformative work already being done in the stem cell field while also helping the society scrutinize the processes that both consciously and unconsciously contribute to an inequitable system.
- April 14, 2022
Following an analysis of over 12,000 human genes, research from Yale Cancer Center indicates there is cancer-relevant importance in a much larger proportion of human genes than current cancer research models suggest. Much of cancer biology research focuses on a few dozen well studied genes called “cancer driver genes.” The new findings demonstrate that a larger number of genes are connected to cancer driver genes and may have an impact on cancer biology. The findings were published in the Journal of the National Cancer Institute.
- March 31, 2022Source: Yale Daily News
Yale researchers have identified specific genes within T-cells that can be amplified to increase a T-cell’s ability to identify and kill cancer cells.
- March 30, 2022
Six years after laying out an ambitious blueprint for the Yale Cancer Biology Institute, much of it has been realized by recruiting scientists with unlimited potential and offering them their first labs. Led by Mark Lemmon, PhD, FRS, the institute has been built around young scientists he calls “superstars.”
- March 23, 2022
Dr. Muzumdar cares for patients with pancreatic cancer and explains how the Yale Pancreatic Cancer Collaborative is working together to search for novel combinations of chemotherapies and targeted therapies to further improve the treatment outcomes for pancreatic cancer.